Pharma
Pharma companies are going all in on rare disease treatments
Drugs designed to treat rare diseases now make up half of new drug approvals each year.
Orphan Drugs
The latest developments in orphan drugs, tracking policy changes and industry innovations driving today's healthcare conversation.
Navigate the healthcare industry
Healthcare Brew covers pharmaceutical developments, health startups, the latest tech, and how it impacts hospitals and providers to keep administrators and providers informed.
By subscribing, you accept our Terms & Privacy Policy.
